Browse by author
Lookup NU author(s): Professor Alan Calvert
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The taxane diterpenes form a group of novel cytotoxic agents of which paclitaxel is thee first to he introduced into clinical practice for the treatment of platinum-refractory or recurrent ovarian cancer. These drugs are natural products with unique mechanisms of action and toxicity profiles. They demonstrate activity in several other malignancies. The widespread use of these drugs is (sic).
Author(s): Bailey, N., Calvert, A. H.
Publication type: Article
Publication status: Published
Journal: British Journal of Hospital Medicine
Year: 1995
Volume: 53
Issue: 1-2
Pages: 10-13
Print publication date: 18/01/1995
ISSN (print): 1750-8460
ISSN (electronic):
